{"id":"rotavirus-vaccine-rotarix","safety":{"commonSideEffects":[{"rate":null,"effect":"Diarrhea"},{"rate":null,"effect":"Vomiting"},{"rate":null,"effect":"Fever"},{"rate":null,"effect":"Irritability"}]},"_chembl":{"chemblId":"CHEMBL6068351","moleculeType":"Vaccine component"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"The vaccine contains a weakened strain of rotavirus that replicates in the intestinal tract, triggering both humoral (antibody) and cell-mediated immune responses without causing disease. This primes the immune system to recognize and neutralize wild-type rotavirus upon natural exposure, preventing severe rotavirus gastroenteritis.","oneSentence":"ROTARIX is a live attenuated rotavirus vaccine that stimulates the immune system to produce antibodies and cellular immunity against rotavirus infection.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T00:06:10.011Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Prevention of rotavirus gastroenteritis in infants and young children"}]},"trialDetails":[{"nctId":"NCT06824194","phase":"PHASE3","title":"Study of the Safety of a 21-valent Pneumococcal Conjugate Vaccine in Healthy Infants From Approximately 2 Months of Age","status":"RECRUITING","sponsor":"Sanofi","startDate":"2025-02-18","conditions":"Pneumococcal Immunization","enrollment":2320},{"nctId":"NCT07348692","phase":"PHASE3","title":"Lot-to-lot Consistency Study of a 21-valent Pneumococcal Conjugate Vaccine in Healthy Infants From 2 Months of Age","status":"RECRUITING","sponsor":"Sanofi","startDate":"2026-01-20","conditions":"Pneumococcal Immunization, Healthy Volunteers","enrollment":896},{"nctId":"NCT06824181","phase":"PHASE3","title":"Study of Mixed Vaccination Schedules With a 21-valent Pneumococcal Conjugate Vaccine and a 20-valent Pneumococcal Conjugate Vaccine in Healthy Infants From Approximately 2 Months of Age","status":"ACTIVE_NOT_RECRUITING","sponsor":"Sanofi","startDate":"2025-02-27","conditions":"Pneumococcal Immunization","enrollment":580},{"nctId":"NCT03621670","phase":"PHASE3","title":"Safety and Immunogenicity of GSK Meningococcal Group B Vaccine and 13-valent Pneumococcal Vaccine Administered Concomitantly With Routine Infant Vaccines to Healthy Infants","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2018-07-27","conditions":"Infections, Meningococcal","enrollment":1196},{"nctId":"NCT01871038","phase":"","title":"Effectiveness of Monovalent Rotavirus Vaccine (RV1)","status":"COMPLETED","sponsor":"Children's Hospital Medical Center, Cincinnati","startDate":"2009-07","conditions":"Rotavirus, Acute Gastroenteritis","enrollment":362},{"nctId":"NCT06647407","phase":"PHASE1, PHASE2","title":"Safety and Immunogenicity of an Investigational Pentavalent Meningococcal ABCYW Vaccine Against Meningococcal Disease in Children, Toddlers, and Infants","status":"ACTIVE_NOT_RECRUITING","sponsor":"Sanofi Pasteur, a Sanofi Company","startDate":"2024-11-05","conditions":"Meningococcal Immunization, Healthy Volunteers","enrollment":750},{"nctId":"NCT06331156","phase":"PHASE3","title":"A Study on the Immune Response and Safety of Inactivated Poliovirus Vaccine (IPV) When Co-administered With Human Rotavirus (HRV) Porcine Circovirus (PCV)-Free Vaccine in Healthy Chinese Infants","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2024-03-22","conditions":"Gastroenteritis","enrollment":400},{"nctId":"NCT04429295","phase":"PHASE3","title":"Study of DTwP-HepB-Hib-IPV (SHAN6™) Vaccine Administered Concomitantly With Routine Pediatric Vaccines to Healthy Infants and Toddlers in Thailand","status":"COMPLETED","sponsor":"Sanofi Pasteur, a Sanofi Company","startDate":"2020-06-28","conditions":"Pertussis Immunisation, Diphtheria Immunisation, Polio Immunisation","enrollment":460},{"nctId":"NCT04658914","phase":"PHASE2","title":"Human Challenge With Live-attenuated Rotavirus to Assess Next-generation Rotavirus Vaccines in Africa","status":"COMPLETED","sponsor":"Centre for Infectious Disease Research in Zambia","startDate":"2021-04-15","conditions":"Diarrhea, Diarrhea Rotavirus","enrollment":720},{"nctId":"NCT06025695","phase":"PHASE3","title":"Immunogenicity, Reactogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Rotarix Porcine Circovirus (PCV)-Free Liquid Compared to Rotarix Liquid Given in 2-doses in Healthy Chinese Infants Starting at Age 6-16 Weeks","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2023-09-01","conditions":"Gastroenteritis","enrollment":2000},{"nctId":"NCT01375647","phase":"PHASE3","title":"Exploration of the Biologic Basis for Underperformance of Oral Polio and Rotavirus Vaccines in Bangladesh","status":"COMPLETED","sponsor":"University of Vermont","startDate":"2011-05","conditions":"Rotavirus Diarrhea, Vaccine Virus Shedding, Tropical Enteropathy","enrollment":700},{"nctId":"NCT06882070","phase":"","title":"ROTA-biotic: Measuring the Impact of Rotavirus Vaccines on Paediatric Antibiotic Usage","status":"COMPLETED","sponsor":"Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)","startDate":"2021-05-04","conditions":"Rotavirus Gastroenteritis, Rotavirus Vaccines, Antimicrobial Resistance (AMR)","enrollment":1600},{"nctId":"NCT02941107","phase":"PHASE4","title":"Optimising Rotavirus Vaccine in Aboriginal Children","status":"ACTIVE_NOT_RECRUITING","sponsor":"Telethon Kids Institute","startDate":"2018-03-27","conditions":"Viral Gastroenteritis Due to Rotavirus","enrollment":1000},{"nctId":"NCT03632720","phase":"PHASE3","title":"Immunogenicity and Safety of a Quadrivalent Meningococcal Conjugate Vaccine in Infants and Toddlers When Administered Concomitantly With Routine Pediatric Vaccines in the United Kingdom","status":"COMPLETED","sponsor":"Sanofi Pasteur, a Sanofi Company","startDate":"2018-10-10","conditions":"Healthy Volunteers (Meningococcal Infection)","enrollment":788},{"nctId":"NCT04031846","phase":"PHASE3","title":"Safety, Tolerability, and Immunogenicity of V114 in Healthy Infants (V114-025)","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2019-09-04","conditions":"Pneumococcal Infections","enrollment":1184},{"nctId":"NCT04344054","phase":"PHASE2","title":"Mixed Schedule Study of Live Oral Rotavirus Vaccines and Trivalent P2-VP8 Subunit Rotavirus Vaccine","status":"COMPLETED","sponsor":"PATH","startDate":"2021-02-22","conditions":"Rotavirus Vaccine","enrollment":850},{"nctId":"NCT03587389","phase":"PHASE4","title":"Response to Rotavirus Vaccine in Infants in Ho Chi Minh City in Vietnam","status":"COMPLETED","sponsor":"Oxford University Clinical Research Unit, Vietnam","startDate":"2019-03-19","conditions":"Rotavirus, Diarrhea","enrollment":818},{"nctId":"NCT01049035","phase":"PHASE2","title":"A Study of a Quadrivalent Meningococcal Tetanus Protein Conjugate Vaccine in Infants and Toddlers","status":"COMPLETED","sponsor":"Sanofi Pasteur, a Sanofi Company","startDate":"2009-12-16","conditions":"Meningitis, Meningococcal Infection","enrollment":580},{"nctId":"NCT03954743","phase":"PHASE3","title":"Safety Study of 2 Formulations of GSK's Human Rotavirus (HRV) Vaccine (444563), in Healthy Infants Starting at Age 6-12 Weeks","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2019-07-19","conditions":"Infections, Rotavirus","enrollment":1351},{"nctId":"NCT01273077","phase":"","title":"Evaluation of Universal Rotavirus Vaccination Program","status":"COMPLETED","sponsor":"Dalhousie University","startDate":"2010-12","conditions":"Gastrointestinal Diseases","enrollment":12705},{"nctId":"NCT02482636","phase":"PHASE2","title":"Baby Vaccine Study (Sched3)","status":"COMPLETED","sponsor":"University of Oxford","startDate":"2015-08","conditions":"Infectious Diseases","enrollment":189},{"nctId":"NCT04010448","phase":"PHASE3","title":"A Trial to Assess the Safety, Immunogenicity and Efficacy of a Trivalent Rotavirus P2-VP8 Subunit Vaccine in Prevention of Severe Rotavirus Gastroenteritis in Healthy Infants in Africa and India","status":"UNKNOWN","sponsor":"PATH","startDate":"2019-10-10","conditions":"Rotavirus Infection of Children","enrollment":8200},{"nctId":"NCT00353366","phase":"","title":"To Evaluate Safety & Reactogenicity of GSK Bio's Human Rotavirus (HRV) Vaccine in Filipino Infants at Least 6 Weeks of Age at First Vaccination","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2006-11-16","conditions":"Infections, Rotavirus, Rotavirus Vaccines","enrollment":1439},{"nctId":"NCT03207750","phase":"PHASE3","title":"This Study Will Evaluate the Immunogenicity, Reactogenicity and Safety of the Routine Infant Vaccines Pediarix®, Hiberix® and Prevenar 13® When Co-administered With GlaxoSmithKline (GSK) Biologicals' Liquid Human Rotavirus Vaccine (HRV) as Compared to GSK's Licensed Lyophilized Vaccine","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2017-09-14","conditions":"Rotavirus Infection, Rotavirus Vaccines","enrollment":1280},{"nctId":"NCT03602053","phase":"PHASE2, PHASE3","title":"Study of BBIL's ROTAVAC® and ROTAVAC 5CM Vaccines in Zambia","status":"COMPLETED","sponsor":"Centre for Infectious Disease Research in Zambia","startDate":"2019-01-22","conditions":"Diarrhea, Diarrhea Rotavirus","enrollment":450},{"nctId":"NCT02141204","phase":"PHASE3","title":"Immunogenicity, Reactogenicity and Safety Study of Two Different Formulations of GSK Biologicals' Human Rotavirus Vaccine, Rotarix, in Healthy Infants","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2019-02-20","conditions":"Rotavirus","enrollment":451},{"nctId":"NCT00263666","phase":"PHASE2","title":"A Study of Safety, Reactogenicity and Immunogenicity of HRV Vaccine in HIV Infected Infants in South Africa","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2005-03-16","conditions":"Infections, Rotavirus","enrollment":100},{"nctId":"NCT01896596","phase":"PHASE4","title":"Hepatitis B Vaccination in Infants","status":"COMPLETED","sponsor":"Public Health England","startDate":"2013-07","conditions":"Meningococcal Disease, Pneumococcal Disease, Haemophilus Influenzae Serotype b Disease","enrollment":300},{"nctId":"NCT02992197","phase":"PHASE4","title":"The Effects of Increased Inoculum on Oral Rotavirus Vaccine Take and Immunogenicity","status":"COMPLETED","sponsor":"University of Vermont","startDate":"2017-06-12","conditions":"Rotavirus Infection, Vaccine Response Impaired, Vaccine Virus Shedding","enrollment":220},{"nctId":"NCT02914184","phase":"PHASE3","title":"Evaluation of Immunogenicity and Safety of Two Formulations of GSK Biologicals' Human Rotavirus (HRV) Vaccine (444563), in Healthy Infants Starting at Age 6-12 Weeks","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2016-10-27","conditions":"Infections, Rotavirus, Rotavirus Vaccines","enrollment":1612},{"nctId":"NCT00750893","phase":"","title":"Evaluation of Reactogenicity and Safety of GSK Biologicals' Rotarix (Human Rotavirus Vaccine) in Infants","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2008-09-02","conditions":"Infections, Rotavirus","enrollment":3111},{"nctId":"NCT00969228","phase":"PHASE4","title":"Study to Evaluate Immunogenicity, Reactogenicity and Safety of Rotarix™ Vaccine in Korean Infants","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2009-08-25","conditions":"Infections, Rotavirus, Rotavirus Vaccines","enrollment":684},{"nctId":"NCT00489554","phase":"PHASE3","title":"Primary Vaccination Study With a Pneumococcal Conjugate Vaccine in Healthy Children 6 to 12wks of Age","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2007-07-03","conditions":"Infections, Streptococcal, Streptococcus Pneumoniae Vaccines","enrollment":230},{"nctId":"NCT01177826","phase":"","title":"Effectiveness Study of GSK Biologicals' Rotarix TM Vaccine in Hospitalized Children","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2008-02-23","conditions":"Infections, Rotavirus, Rotavirus Vaccines","enrollment":643},{"nctId":"NCT00970307","phase":"PHASE2","title":"Immunogenicity and Safety Study of GSK Biologicals' GSK2202083A Vaccine in Healthy Infants at 2, 3 and 4 Months of Age","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2009-08-13","conditions":"Tetanus, Diphtheria, Haemophilus Influenzae Type b","enrollment":421},{"nctId":"NCT00432380","phase":"PHASE2","title":"A Study to Evaluate Immune Response and Safety of Two Doses of GSK Biologicals' HRV Liquid Vaccine in Healthy Infants.","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2007-03-09","conditions":"Infections, Rotavirus, Rotavirus Vaccines","enrollment":375},{"nctId":"NCT00480324","phase":"PHASE3","title":"Efficacy, Safety, Reactogenicity & Immunogenicity of the Rotarix Vaccine in Japanese Infants","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2007-06-19","conditions":"Infections, Rotavirus, Rotavirus Vaccines","enrollment":765},{"nctId":"NCT01309646","phase":"PHASE3","title":"Immunogenicity and Safety of GlaxoSmithKline Biologicals' Infanrix™-IPV+Hib Vaccine","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2011-03-04","conditions":"Poliomyelitis, Tetanus, Acellular Pertussis","enrollment":454},{"nctId":"NCT02096263","phase":"PHASE3","title":"Study to Determine the Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals; Infanrix Hexa at 2, 4 and 6 Months of Age in Healthy Infants","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2014-04-16","conditions":"Poliomyelitis, Diphtheria, Haemophilus Influenzae Type b","enrollment":585},{"nctId":"NCT02907216","phase":"PHASE4","title":"Evaluation of Immunogenicity and Safety of the Diphtheria, Tetanus, Pertussis and Inactivated Poliovirus (DPT-IPV) Vaccine Squarekids Co-administered With GSK Biologicals' Human Rotavirus (HRV) Vaccine Rotarix (GSK444563) in Healthy Infants","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2016-09-16","conditions":"Rotavirus","enrollment":292},{"nctId":"NCT04123119","phase":"NA","title":"Development of a Live Attenuated Rotavirus Vaccine as a Human Infection Challenge Model","status":"COMPLETED","sponsor":"Centre for Infectious Disease Research in Zambia","startDate":"2019-01-22","conditions":"Diarrhoeal Disease","enrollment":22},{"nctId":"NCT03507738","phase":"PHASE1","title":"Safety and Immunogenicity of MT-5625 in Healthy Adults, Toddlers and Infants","status":"COMPLETED","sponsor":"Tanabe Pharma Corporation","startDate":"2018-07-03","conditions":"Healthy","enrollment":110},{"nctId":"NCT01345240","phase":"PHASE3","title":"Study to Evaluate Immunogenicity of the Hepatitis B Antigen of the GSK Biologicals' Candidate Malaria Vaccine (257049)","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2011-11-17","conditions":"Malaria, Malaria Vaccines","enrollment":705},{"nctId":"NCT01480258","phase":"PHASE3","title":"Safety, Tolerability, and Immunogenicity of V419 in Healthy Infants When Given at 2, 4, and 11 to 12 Months (V419-008)","status":"COMPLETED","sponsor":"MCM Vaccines B.V.","startDate":"2011-11-23","conditions":"Bacterial Infections, Virus Diseases","enrollment":1315},{"nctId":"NCT01700621","phase":"PHASE4","title":"Coadministration of Measles-rubella and Rotavirus Vaccines","status":"COMPLETED","sponsor":"PATH","startDate":"2013-01","conditions":"Measles Antibody Seroconversion, Rubella Antibody Seroconversion, Rotavirus Geometric Mean Titer (GMT)","enrollment":482},{"nctId":"NCT00875641","phase":"","title":"Safety Study of GSK Biologicals' Rotavirus Vaccine (Rotarix®) Administered to Children Aged <1 Year in the United States","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2009-04-20","conditions":"Infections, Rotavirus","enrollment":390659},{"nctId":"NCT01616693","phase":"PHASE4","title":"Zinc and/or Probiotic Supplementation of Rotavirus and Oral Polio Virus Vaccines","status":"COMPLETED","sponsor":"PATH","startDate":"2012-07","conditions":"Immunity to Oral Rotavirus Vaccine, Immunity to Oral Polio Vaccine, Shedding of Oral Rotavirus Vaccine","enrollment":620},{"nctId":"NCT02002156","phase":"PHASE4","title":"A Study of the Interaction Between BCG And MenC Immunisation: BAM","status":"COMPLETED","sponsor":"University of Oxford","startDate":"2014-06-20","conditions":"BCG Infection, Reaction - Vaccine, Immune Response","enrollment":28},{"nctId":"NCT01119625","phase":"PHASE3","title":"Immunological Persistence After Priming With GSK1024850A Vaccine and Safety& Immunogenicity After Booster Dose","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2010-07-12","conditions":"Infections, Streptococcal","enrollment":238},{"nctId":"NCT01978093","phase":"PHASE3","title":"Immunogenicity, Safety and Reactogenicity Study of GlaxoSmithKline (GSK) Biologicals' Hib-MenCY-TT (MenHibrix®) Vaccine Compared to Merck & Co, Inc. PedvaxHIB Vaccine in Healthy Infants and Toddlers 12 to 15 Months of Age","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2014-02-01","conditions":"Neisseria Meningitidis, Haemophilus Influenzae Type b","enrollment":600},{"nctId":"NCT02584816","phase":"PHASE3","title":"Phase III Study on Rotavirus Vaccine to Evaluate Lot-to-lot Consistency and Interference With Routine UIP Immunization","status":"COMPLETED","sponsor":"Serum Institute of India Pvt. Ltd.","startDate":"2015-11","conditions":"Rotavirus Gastroenteritis","enrollment":1500},{"nctId":"NCT00779779","phase":"","title":"Evaluation of Reactogenicity and Safety of GSK Biologicals' Rotarix™ (Human Rotavirus Vaccine) in Infants","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2008-11-22","conditions":"Infections, Rotavirus","enrollment":522},{"nctId":"NCT00420316","phase":"PHASE3","title":"Long-term Efficacy and Safety of Subjects Approximately 3 Years After Priming With 2 Doses of GSK Bio's HRV Vaccine.","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2007-02-12","conditions":"Infections, Rotavirus","enrollment":1613},{"nctId":"NCT01090453","phase":"PHASE2","title":"Study of GlaxoSmithKline Biologicals' GSK2202083A Vaccine in Healthy Infants","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2010-05-17","conditions":"Tetanus, Hepatitis B, Haemophilus Influenzae Type b","enrollment":480},{"nctId":"NCT01198769","phase":"PHASE4","title":"Immunogenicity and Safety Study of Rotarix TM in Taiwanese Infants Who Received Hepatitis B Immunoglobulin After Birth.","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2010-11-11","conditions":"Infections, Rotavirus","enrollment":15},{"nctId":"NCT00829010","phase":"PHASE3","title":"Primary and Booster Vaccination Study With a Pneumococcal Vaccine in HIV Infected, HIV Exposed Uninfected and HIV Uninfected Children 6 to 10 Weeks of Age.","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2009-02-17","conditions":"Infections, Streptococcal","enrollment":489},{"nctId":"NCT00808444","phase":"PHASE3","title":"Primary Vaccination Study With a Pneumococcal Conjugate Vaccine in Healthy Children 6-12wks of Age","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2009-01-05","conditions":"Infections, Streptococcal","enrollment":466},{"nctId":"NCT02193061","phase":"PHASE3","title":"Randomized, Controlled Single-blind Clinical Study to Assess Vaccine Interchangeability Between RV5 and RV1 Using Seven Combined Anti-rotavirus Prevention Programs","status":"COMPLETED","sponsor":"National Institute of Pediatrics, Mexico","startDate":"2013-11","conditions":"Rotavirus Vaccine","enrollment":1498},{"nctId":"NCT01171963","phase":"PHASE3","title":"Study to Assess the Efficacy, Immunogenicity and Safety of Liquid Human Rotavirus Vaccine, in Healthy Chinese Infants","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2010-08-29","conditions":"Infections, Rotavirus","enrollment":3340},{"nctId":"NCT02847026","phase":"PHASE4","title":"Fractional Inactivated Poliovirus Vaccine Booster and Rotavirus Study","status":"COMPLETED","sponsor":"Centers for Disease Control and Prevention","startDate":"2016-09","conditions":"Poliomyelitis","enrollment":1144},{"nctId":"NCT01000974","phase":"PHASE3","title":"Consistency & Immunogenicity Study of 3 Lots of GSK's Hib Conjugate Vaccine Versus ActHIB & Pentacel in Healthy Infants","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2010-06-18","conditions":"Haemophilus Influenzae Type b","enrollment":4003},{"nctId":"NCT02542462","phase":"PHASE4","title":"Potential Mechanisms for Intussusception After Rotavirus Vaccine-Pilot Study","status":"COMPLETED","sponsor":"Children's Hospital Medical Center, Cincinnati","startDate":"2015-11","conditions":"Intussusception, Rotavirus Infections","enrollment":144},{"nctId":"NCT00420745","phase":"PHASE3","title":"To Assess Safety, Reactogenicity & Immunogenicity of 2 Doses of GSK's Oral Human Rotavirus Vaccine in Pre-Term Infants","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2007-01-25","conditions":"Infections, Rotavirus","enrollment":1009},{"nctId":"NCT00533507","phase":"PHASE3","title":"Primary Vaccination Study With a Pneumococcal Conjugate Vaccine in Healthy Children 6 to 8 Weeks of Age","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2007-09-18","conditions":"Infections, Rotavirus","enrollment":230},{"nctId":"NCT00363545","phase":"PHASE3","title":"To Assess Immunogenicity, Reactogenicity & Safety of 2 Formulations of GSK's HRV Vaccine as 2-dose Vaccination (Infants)","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2006-09-01","conditions":"Infections, Rotavirus","enrollment":1274},{"nctId":"NCT00158756","phase":"PHASE3","title":"Immune Response Post Pry Vaccination of 2 Formulations of DTPw-HBV Vaccine Given With Rotavirus Vaccine to Infants","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2005-09-12","conditions":"Hepatitis B","enrollment":308},{"nctId":"NCT00325143","phase":"PHASE3","title":"Safety of DTPa-IPV/Hib & DTPa-HBV-IPV/Hib, Followed by DTPa-IPV/Hib Vaccine in Infants Who Received Hepatitis B Vaccine","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2003-12-01","conditions":"Haemophilus Influenzae Type b, Diphtheria, Tetanus","enrollment":702},{"nctId":"NCT00396630","phase":"PHASE3","title":"A Study to Explore the Existence of Horizontal Transmission of the RIX4414 Vaccine Strain Between Twins Within a Family.","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2007-01-23","conditions":"Infections, Rotavirus","enrollment":200},{"nctId":"NCT00938327","phase":"","title":"Reactogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Rotarix™ (Human Rotavirus Vaccine) in Indian Infants","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2009-08-03","conditions":"Infections, Rotavirus","enrollment":332},{"nctId":"NCT00653198","phase":"","title":"Effectiveness of Rotarix™ Against Rotavirus Severe Gastroenteritis (RV SGE) in Infants in Panama","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2008-03-19","conditions":"Infections, Rotavirus","enrollment":885},{"nctId":"NCT01236066","phase":"","title":"Impact of Rotavirus Vaccination on Hospitalisations for Rotavirus Gastroenteritis in Children Aged <5 Years in Australia","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2010-10","conditions":"Rotavirus Gastroenteritis, Gastroenteritis","enrollment":1},{"nctId":"NCT00655187","phase":"","title":"Effectiveness of Human Rotavirus Vaccine, Rotarix™ Against Rotavirus Severe Gastroenteritis (RV SGE) in Infants","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2008-04","conditions":"Rotavirus Severe Gastroenteritis","enrollment":1270},{"nctId":"NCT01086436","phase":"PHASE1","title":"Study to Evaluate the Safety of Rotarix™ in Chinese Children","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2010-03-13","conditions":"Infections, Rotavirus","enrollment":50},{"nctId":"NCT01162590","phase":"PHASE1","title":"Study to Evaluate the Reactogenicity and Safety of Rotarix™ in Chinese Adults","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2010-03-01","conditions":"Infections, Rotavirus","enrollment":52},{"nctId":"NCT01511133","phase":"","title":"Serological Response to Porcine Circovirus Type 1 (PCV-1) and PCV-1 DNA in Stools of Infants Following Administration of Rotarix™","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2010-04","conditions":"Rotavirus Infection, Evidence of PCV-1 Replication and/or Immune Response to the PCV-1 in HRV Vaccinated Infants","enrollment":1},{"nctId":"NCT00370318","phase":"PHASE3","title":"Prophylactic Antipyretic Treatment in Children Receiving Pneumococcal Conjugate and Standard Infant Vaccines","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2006-09","conditions":"Infections, Rotavirus","enrollment":400},{"nctId":"NCT03031743","phase":"","title":"The Influence of the Microbiome on Rotavirus Vaccine Immunogenic Response in Infants in Karachi, Pakistan","status":"COMPLETED","sponsor":"Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)","startDate":"2014-01","conditions":"Rotavirus","enrollment":88},{"nctId":"NCT01339221","phase":"","title":"Epidemiological, Observational and Post Marketing Study of Rotarix™ in Children With Severe Gastroenteritis in Belgium","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2011-03","conditions":"Infections, Rotavirus","enrollment":72},{"nctId":"NCT00241644","phase":"PHASE3","title":"Vaccine Efficacy Against Rotavirus Diarrhea; Vaccine Given With Routine Childhood Vaccinations in Healthy African Infants","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2005-10","conditions":"Infections, Rotavirus","enrollment":2089},{"nctId":"NCT00329745","phase":"PHASE3","title":"Year 3 Extension for Efficacy Follow-up in Subjects Vaccinated in Studies Rota-028, 029 or 030 (NCT00197210)","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2007-01","conditions":"Infections, Rotavirus","enrollment":8687},{"nctId":"NCT00429481","phase":"PHASE2","title":"Assess Efficacy, Immune Response & Safety of 2 Doses of Oral Live Attenuated HRV Vaccine at Different Viral Concentrations in Healthy Infants","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2001-01","conditions":"Hepatitis B","enrollment":2464},{"nctId":"NCT00425737","phase":"PHASE2","title":"Assess Efficacy, Immune Response & Safety of 2 Doses of Oral Live Attenuated HRV Vaccine in Healthy Infants","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2000-08","conditions":"Infections, Rotavirus","enrollment":405},{"nctId":"NCT00757770","phase":"PHASE3","title":"Assessment of Clinical Consistency of Three Production Lots of GSK Biologicals' HRV Vaccine","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2003-08","conditions":"Infections, Rotavirus","enrollment":854},{"nctId":"NCT01377571","phase":"PHASE2","title":"A Dose-escalating Study to Evaluate the Immunogenicity and Safety of Rotavin-M1 Vaccine in Healthy Infants","status":"COMPLETED","sponsor":"National Institute of Hygiene and Epidemiology, Vietnam","startDate":"2009-10","conditions":"Diarrhea, Fever, Nausea","enrollment":200},{"nctId":"NCT01983540","phase":"PHASE3","title":"Antibody Persistence at Age 3.5 and 4.5 Years After Primary and Booster DTaP-IPV-Hep B-PRP~T or Infanrix Hexa Vaccination","status":"COMPLETED","sponsor":"Sanofi Pasteur, a Sanofi Company","startDate":"2013-10","conditions":"Diphtheria, Tetanus, Whooping Cough","enrollment":558},{"nctId":"NCT00995813","phase":"PHASE4","title":"Pilot Study of the Rotavirus Vaccine in Infants With Intestinal Failure","status":"COMPLETED","sponsor":"Seattle Children's Hospital","startDate":"2009-12","conditions":"Intestinal Failure, Rotavirus Vaccines","enrollment":15},{"nctId":"NCT01636739","phase":"","title":"Special Drug Use Investigation for ROTARIX®","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2012-07","conditions":"Infections, Rotavirus","enrollment":10982},{"nctId":"NCT01003431","phase":"PHASE3","title":"A Study of the Immunogenicity and Safety of Whole-Cell Pertussis Containing Vaccine Administered Concomitantly With RotaTeq™ (V260) or Rotarix™ (V260-036)(WITHDRAWN)","status":"WITHDRAWN","sponsor":"Merck Sharp & Dohme LLC","startDate":"2009-12","conditions":"Rotavirus Gastroenteritis, Diphtheria, Tetanus","enrollment":""},{"nctId":"NCT01636193","phase":"","title":"Drug Use Investigation for ROTARIX®","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2012-06","conditions":"Infections, Rotavirus","enrollment":1607},{"nctId":"NCT01575197","phase":"PHASE4","title":"Evaluation of the Human Rotavirus Vaccine at Varying Schedules and Doses in Rural Ghana","status":"COMPLETED","sponsor":"PATH","startDate":"2012-09","conditions":"Rotavirus Gastroenteritis","enrollment":456},{"nctId":"NCT02153333","phase":"","title":"Serologic Response to Porcine Circovirus Type 1 (PCV-1) in Infants Following Administration of Rotarix™","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2014-02","conditions":"Infections, Rotavirus","enrollment":1},{"nctId":"NCT01110044","phase":"PHASE2","title":"Study of a Birth Dose of GlaxoSmithKline Biologicals' 251154 Vaccine","status":"WITHDRAWN","sponsor":"GlaxoSmithKline","startDate":"2010-04","conditions":"Infections, Rotavirus","enrollment":""},{"nctId":"NCT01435967","phase":"","title":"Observational Study on Rotavirus Gastroenteritis Epidemiology, Impact of Lyophilised vs. Liquid Formulation of Rotarix™","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2011-09","conditions":"Infections, Rotavirus","enrollment":1},{"nctId":"NCT01978223","phase":"","title":"Effectiveness of RotarixTM Vaccine in Children Aged Between 12 Weeks to < 5 Years, Hospitalised for Severe Gastroenteritis","status":"WITHDRAWN","sponsor":"GlaxoSmithKline","startDate":"2014-12","conditions":"Infections, Rotavirus","enrollment":""},{"nctId":"NCT01915888","phase":"","title":"Study to Analyze the Clinical and Cost Impact of Complete and Incomplete Rotarix Vaccination","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2013-08","conditions":"Infections, Rotavirus","enrollment":1},{"nctId":"NCT01266850","phase":"PHASE4","title":"Safety and Immunogenicity of Sequential Rotavirus Vaccine Schedules","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2011-03","conditions":"Rotavirus Infection","enrollment":1384},{"nctId":"NCT01682005","phase":"","title":"Study to Analyze the Clinical and Cost Impact of Complete and Incomplete Rotavirus (RV) Vaccination","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2012-08","conditions":"Infections, Rotavirus","enrollment":1},{"nctId":"NCT02220439","phase":"","title":"Does the Fecal Microbiome Influence Rotarix Immunogenicity","status":"COMPLETED","sponsor":"Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)","startDate":"2013-09","conditions":"Rotavirus Infections, Reaction - Vaccine Nos, Intestinal Bacteria Flora Disturbance","enrollment":76},{"nctId":"NCT01841671","phase":"PHASE4","title":"Immunogenicity of 1 or 2 Doses of bOPV in Chilean Infants Primed With IPV Vaccine","status":"UNKNOWN","sponsor":"University of Chile","startDate":"2013-04","conditions":"Polio","enrollment":570},{"nctId":"NCT01177722","phase":"PHASE3","title":"A Study of DTaP-IPV-Hep B-PRP-T Vaccine Given With Prevenar™ and Rotarix™ in Healthy Latin American Infants","status":"COMPLETED","sponsor":"Sanofi Pasteur, a Sanofi Company","startDate":"2010-08","conditions":"Diphtheria, Tetanus, Whooping Cough","enrollment":1375}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":89,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["ROTARIX"],"phase":"marketed","status":"active","brandName":"Rotavirus Vaccine (ROTARIX)","genericName":"Rotavirus Vaccine (ROTARIX)","companyName":"International Centre for Diarrhoeal Disease Research, Bangladesh","companyId":"international-centre-for-diarrhoeal-disease-research-bangladesh","modality":"Biologic","firstApprovalDate":"","aiSummary":"ROTARIX is a live attenuated rotavirus vaccine that stimulates the immune system to produce antibodies and cellular immunity against rotavirus infection. Used for Prevention of rotavirus gastroenteritis in infants and young children.","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}